1744-666X
3.9
否
不在预警名单内
否
Q2区
2005
Bimonthly
医学
UNITED STATES
Taylor and Francis Ltd.
SCIE,Scopus
108
5.4
-
Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology. Articles focus on the following key areas:• Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines• Performance and benefits of newly approved therapeutic agents• New diagnostic approaches• Screening and patient stratification• Pharmacoeconomic studies• New therapeutic indications for existing therapies• Adverse effects, occurrence and reduction• Prospects for medicines in late-stage trials approaching regulatory approval• Novel treatment strategies• Epidemiological studies• Commentary and comparison of treatment guidelines Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases.
临床免疫学专家评论(ISSN 1744- 666 X)提供了关于临床免疫学中新的治疗和诊断模式的性能的专家分析和评论。《临床免疫学专家评论》国际编辑咨询小组的成员是他们专业领域的前沿。该专家组与我们专门的编辑团队合作,确定最重要和最热门的评论主题,以及最适合提供评论和分析的相应专家。所有文章都经过严格的同行评审,完成的评审为临床免疫学决策提供了重要贡献。文章集中在以下关键领域:·特定免疫疾病的治疗概述,强调最佳治疗和新药的前景·新批准的治疗药物的性能和益处·新的诊断方法·筛选和患者分层·药物经济学研究·现有疗法的新治疗适应症·不良反应、发生率和减少·接近监管批准的后期试验药物的前景·新的治疗策略·流行病学研究·治疗指南的评论和比较主题包括感染和免疫、炎症、宿主防御机制、先天性和获得性免疫缺陷、过敏反应和变态反应、全身免疫疾病、器官特异性炎症性疾病、移植免疫学、内分泌学和糖尿病、癌症免疫学、神经免疫学和血液学疾病。
《Expert Review of Clinical Immunology》期刊已被查看: 次
如果你是第一次发表SCI的话,我还是建议你啊,花钱找一个好的老师,一呢是让你尽快拿到一个结果,有一个好的开始啊,二是为了摸清套路,也对自己未来的科研路呢,能起到
JCR:Q2区--分类:医学
影响因子2.8
收录SCIE,Scopus,ssci
JCR:Q4区--分类:医学
影响因子0.6
收录SCIE,Scopus,DOAJ开放期刊
JCR:Q2区--分类:医学
影响因子1.8
收录SCIE,Scopus
JCR:Q1区--分类:医学
影响因子4.7
收录SCIE,Scopus
JCR:Q1区--分类:医学
影响因子3.4
收录SCIE,Scopus,ssci
JCR:Q4区--分类:医学
影响因子1.1
收录SCIE,Scopus
JCR:Q4区--分类:医学
影响因子0.4
收录SCIE,Scopus
JCR:Q4区--分类:医学
影响因子0.9
收录SCIE,Scopus